Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL1535282 | 0.77 | ALDH1A1 (0.48) | ALDH1A1FKBP5 | |
| Imidazole SCHEMBL703024 | 0.76 | ALDH1A1 (0.39) | ALDH1A1FKBP5 | |
| Pyrophosphoric Acid SCHEMBL8011246 | 0.76 | ALDH1A1 (0.56) | ALDH1A1FKBP5 | |
| Pyrophosphoric Acid SCHEMBL17216548 | 0.76 | ALDH1A1 (0.56) | ALDH1A1FKBP5 | |
| Pyrophosphoric Acid SCHEMBL2482818 | 0.76 | ALDH1A1 (0.56) | ALDH1A1FKBP5 | |
| Phosphoric Acid SCHEMBL22659156 | 0.75 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Phosphoric Acid SCHEMBL29042477 | 0.75 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Phosphoric Acid SCHEMBL1352614 | 0.75 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Phosphoric Acid SCHEMBL1090914 | 0.75 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Phosphoric Acid SCHEMBL27150318 | 0.75 | ALDH1A1 (0.68) | ALDH1A1FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119220476-B | Recombinant escherichia coli construction and application for improving yield of difucosyl lactose | 天津合生领航生物科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| US-20060034817-A1 | Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase | UNIVERSITY OF SOUTH CAROLINA | 2006-02-16 | — | — | US | claimed |
| EP-0813602-A1 | HERBICIDE RESISTANT PLANTS | Ciba-Geigy Japan Limited (JP) | 1997-12-29 | — | — | EP | claimed |
| WO-1994026909-A1 | HERBICIDE RESISTANT PLANTS | JAPAT LTD. (CH) | 1994-11-24 | — | — | WO | claimed |
| US-20250352486-A1 | NANOPARTICLES FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS | UNIVERSITAT POLITÈCNICA DE VALÈNCIA (ES) | 2025-11-20 | — | — | US | disclosed |
| EP-4647496-A1 | NOVEL PROMOTER AND USE THEREOF | CJ CheilJedang Corporation (KR) | 2025-11-12 | — | — | EP | disclosed |
| EP-4529916-A1 | NANOPARTICLES FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS | Universitat Politècnica de València (ES) | 2025-04-02 | — | — | EP | disclosed |
| CN-119220476-B | Recombinant escherichia coli construction and application for improving yield of difucosyl lactose | 天津合生领航生物科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| WO-2023227817-A1 | NANOPARTICLES FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS | UNIVERSITAT POLITÈCNICA DE VALÈNCIA (ES) | 2023-11-30 | — | — | WO | disclosed |
| US-20230348895-A1 | COMPOSITIONS AND METHODS FOR DETERMINING PROVENANCE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230065419-A1 | ENHANCED PRODUCTION OF HISTIDINE, PURINE PATHWAY METABOLITES, AND PLASMID DNA | GINKGO BIOWORKS, INC. (US) | 2023-03-02 | — | — | US | disclosed |
| US-11492616-B2 | Method for modifying amino acid attenuator and use of same in production | INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2022-11-08 | — | — | US | disclosed |
| EP-0897008-A2 | His5 | SMITHKLINE BEECHAM CORPORATION (US) | 1999-02-17 | — | — | EP | disclosed |
| EP-0871750-A2 | REMOVAL OF METALS FROM CONTAMINATED SUBSTRATES BY PLANTS | ISIS INNOVATION LIMITED (GB) | 1998-10-21 | — | — | EP | disclosed |
| US-5723482-A | CARNOSINE OR DERIVATIVE, UROCANIC ACID OR DERIVATIVE | BEIERSDORF AG (DE) | 1998-03-03 | — | — | US | disclosed |
| WO-1997010346-A2 | REMOVAL OF METALS FROM CONTAMINATED SUBSTRATES BY PLANTS | ISIS INNOVATION LIMITED (GB) | 1997-03-20 | — | — | WO | disclosed |
| WO-1996040917-A1 | NOVEL NuMA-INTERACTING PROTEINS AND METHODS FOR THEIR IDENTIFICATION | YALE UNIVERSITY (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0730408-A1 | TRIAZOLE PHOSPHONATE PESTICIDES | AgrEvo UK Limited (GB) | 1996-09-11 | — | — | EP | disclosed |
| WO-1995014385-A1 | TRIAZOLE PHOSPHONATE PESTICIDES | AGREVO UK LIMITED (GB) | 1995-06-01 | — | — | WO | disclosed |
| EP-0054223-A2 | Plasmid vectors for eukaryotic cells and method for selecting transfected eukaryotic cells | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060034817-A1 | Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase | HEXB, AHCYL1, HRH1 | ALDH1A1 1530/4885FKBP5 2688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.